Evidence map›Paper›PMID 28371013›Full record

ArticleAging cell2017

Aging-associated dysregulation of homeostatic immune response termination (and not initiation).

Goutham Pattabiraman, Karol Palasiewicz, John P Galvin, David S Ucker

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Effects of Silibinin on Delaying Aging inAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Macrophages in Lung Repair and Fibrosis.Results and problems in cell differentiation · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Dysregulation of Systemic Immunity in Aging and Dementia.Frontiers in cellular neuroscience · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Goutham PattabiramanDepartment of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Karol PalasiewiczDepartment of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL, 60612, USA.
John P GalvinDepartment of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL, 60612, USA.
David S UckerDepartment of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL, 60612, USA.
University of Illinois Urbana-Champaign · USUniversity of Illinois Chicago · US

Funding

Aging and Apoptotic Modulation of Immune ResponsivenessR01AG029633 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI UCKER, DAVID S · 2008 to 2012
$1.6M
NIA NIH HHS R01 AG029633
6 · The paper itself

Abstract

Immunosenescence is a state of unbalanced immune responsiveness, characterized by a diverse repertoire of seemingly discreet and paradoxical alterations in all aspects of immunity arising in an aging-associated manner. We asked whether aging-associated alterations in the ability of apoptotic cells to elicit immunomodulatory responses (innate apoptotic immunity; IAI) or in IAI responses themselves might underlie the confounding aging-associated anomalies of immunosenescence. We explored this question by examining, as a function of animal age, responsiveness of murine macrophages on the single cell level. We monitored the expression of pro- and anti-inflammatory cytokines cytofluorimetrically in response to pro-inflammatory Toll-like receptor (TLR) stimulation and anti-inflammatory treatment with apoptotic cells. While we found no alterations with age in the potency of apoptotic cells or in the initiation and magnitude of IAI responses, we did identify a cell-intrinsic deficiency in anti-inflammatory IAI response termination linked with age and preceding manifestations of immunosenescence. Further, we found that an aging-associated deficiency in response termination also is evident following TLR stimulation. These surprising observations reveal that a loss of homeostatic immune control with animal age results from the dysregulation of response termination (as distinct from response initiation) and is exerted on the level of transcription. We suggest that, with advancing age, cells become locked into relatively longer-lived response states. Aging-associated immune dysfunctions may reflect a diminution in the cellular nimbleness of immune responsiveness.

Indexed as

Immunity, InnateAge FactorsAnimalsApoptosisGene Expression Regulation, DevelopmentalHomeostasisHumansImmunosenescenceInterleukin-10LipopolysaccharidesMacrophage ActivationMacrophagesMiceMice, Inbred C57BLPrimary Cell CultureSignal TransductionIL10 protein, mouseInterleukin-10LipopolysaccharidesTumor Necrosis Factor-alphaagingapoptosishomeostasisimmunosenescenceinnate immunitymacrophages

Identifiers

PMID28371013
PMCPMC5418197
OpenAlexW2603324334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.